Literature DB >> 21709248

Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice.

Tracy A Bedrosian1, Kamillya L Herring, Zachary M Weil, Randy J Nelson.   

Abstract

Both normal aging and dementia are associated with dysregulation of the biological clock, which contributes to disrupted circadian organization of physiology and behavior. Diminished circadian organization in conjunction with the loss of cholinergic input to the cortex likely contributes to impaired cognition and behavior. One especially notable and relatively common circadian disturbance among the aged is "sundowning syndrome," which is characterized by exacerbated anxiety, agitation, locomotor activity, and delirium during the hours before bedtime. Sundowning has been reported in both dementia patients and cognitively intact elderly individuals living in institutions; however, little is known about temporal patterns in anxiety and agitation, and the neurobiological basis of these rhythms remains unspecified. In the present study, we explored the diurnal pattern of anxiety-like behavior in aged and amyloid precursor protein (APP) transgenic mice. We then attempted to treat the observed behavioral disturbances in the aged mice using chronic nightly melatonin treatment. Finally, we tested the hypothesis that time-of-day differences in acetylcholinesterase and choline acetyltransferase expression and general neuronal activation (i.e., c-Fos expression) coincide with the behavioral symptoms. Our results show a temporal pattern of anxiety-like behavior that emerges in elderly mice. This behavioral pattern coincides with elevated locomotor activity relative to adult mice near the end of the dark phase, and with time-dependent changes in basal forebrain acetylcholinesterase expression. Transgenic APP mice show a similar behavioral phenomenon that is not observed among age-matched wild-type mice. These results may have useful applications to the study and treatment of age- and dementia-related circadian behavioral disturbances, namely, sundowning syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21709248      PMCID: PMC3136261          DOI: 10.1073/pnas.1103098108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine.

Authors:  E E Irvine; S Cheeta; S E File
Journal:  Behav Pharmacol       Date:  1999-11       Impact factor: 2.293

2.  Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy.

Authors:  Richard Mahlberg; Dieter Kunz; Igor Sutej; Klaus-Peter Kühl; Rainer Hellweg
Journal:  J Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.153

3.  Dual projections of single cholinergic and aminergic brainstem neurons to the thalamus and basal forebrain in the rat.

Authors:  B J Losier; K Semba
Journal:  Brain Res       Date:  1993-02-26       Impact factor: 3.252

Review 4.  The nucleus basalis magnocellularis cholinergic system: one hundred years of progress.

Authors:  G L Wenk
Journal:  Neurobiol Learn Mem       Date:  1997-03       Impact factor: 2.877

5.  Sundown syndrome in institutionalized elderly.

Authors:  L K Evans
Journal:  J Am Geriatr Soc       Date:  1987-02       Impact factor: 5.562

6.  Comparison of the effects of aging on 5-HT7 and 5-HT1A receptors in discrete regions of the circadian timing system in hamsters.

Authors:  M J Duncan; J Short; D L Wheeler
Journal:  Brain Res       Date:  1999-05-22       Impact factor: 3.252

7.  Daily timed melatonin feedings mimic effects of short days on testis regression and cortisol in circulation in Siberian hamsters.

Authors:  Sara M Hiebert; Stephen A Green; Steven M Yellon
Journal:  Gen Comp Endocrinol       Date:  2005-12-28       Impact factor: 2.822

8.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

9.  Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test.

Authors:  J D Brioni; A B O'Neill; D J Kim; M W Decker
Journal:  Eur J Pharmacol       Date:  1993-07-06       Impact factor: 4.432

10.  Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.

Authors:  David G Harper; Edward G Stopa; Ann C McKee; Andrew Satlin; David Fish; Ladislav Volicer
Journal:  Neurobiol Aging       Date:  2004-07       Impact factor: 4.673

View more
  27 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Impairments in experience-dependent scaling and stability of hippocampal place fields limit spatial learning in a mouse model of Alzheimer's disease.

Authors:  Rong Zhao; Stephanie W Fowler; Angie C A Chiang; Daoyun Ji; Joanna L Jankowsky
Journal:  Hippocampus       Date:  2014-05-05       Impact factor: 3.899

Review 3.  Rodent models for Alzheimer's disease drug discovery.

Authors:  Daniela Puzzo; Walter Gulisano; Agostino Palmeri; Ottavio Arancio
Journal:  Expert Opin Drug Discov       Date:  2015-04-30       Impact factor: 6.098

Review 4.  Sleep disturbances in Alzheimer's and Parkinson's diseases.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2012-05-03       Impact factor: 3.843

5.  Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice.

Authors:  Xiaoguang Li; Zhihao Wang; Lu Tan; Yali Wang; Chengbiao Lu; Rongxiang Chen; Shujuan Zhang; Yuan Gao; Yanchao Liu; Yaling Yin; Xinghua Liu; Enjie Liu; Ying Yang; Yu Hu; Zhipeng Xu; Fuqiang Xu; Jie Wang; Gong-Ping Liu; Jian-Zhi Wang
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

6.  Voluntary exercise can strengthen the circadian system in aged mice.

Authors:  T L Leise; M E Harrington; P C Molyneux; I Song; H Queenan; E Zimmerman; G S Lall; S M Biello
Journal:  Age (Dordr)       Date:  2013-01-23

Review 7.  Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.

Authors:  Lynn Marie Trotti; Elias G Karroum
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

8.  Anxiety-like behavior as an early endophenotype in the TgF344-AD rat model of Alzheimer's disease.

Authors:  Nathan S Pentkowski; Laura E Berkowitz; Shannon M Thompson; Emma N Drake; Carlos R Olguin; Benjamin J Clark
Journal:  Neurobiol Aging       Date:  2017-10-05       Impact factor: 4.673

9.  Vascular pathology of 20-month-old hypercholesterolemia mice in comparison to triple-transgenic and APPSwDI Alzheimer's disease mouse models.

Authors:  Lindsay A Hohsfield; Nina Daschil; Greger Orädd; Ingrid Strömberg; Christian Humpel
Journal:  Mol Cell Neurosci       Date:  2014-11       Impact factor: 4.314

10.  Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.

Authors:  Elysse M Knight; Timothy M Brown; Sarah Gümüsgöz; Jennifer C M Smith; Elizabeth J Waters; Stuart M Allan; Catherine B Lawrence
Journal:  Dis Model Mech       Date:  2012-08-03       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.